Fenoterol
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Fenoterol is an asthma medication designed to open up the airways to the lungs. It is classed as a beta agonist.
It was a long-acting beta-agonist widely used in New Zealand in the early 1990s but withdrawn because of its association with an excess number of deaths.
References
- Beasley R, Pearce N, Crane J, Burgess C. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):325-7.
- Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20, 1992;326(8):501-6.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
